Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Investor Day

14th Sep 2012 07:00

RNS Number : 1922M
United Drug PLC
14 September 2012
 



 

 

UNITED DRUG PLC

 

INVESTOR DAY

 

14 September 2012: United Drug plc ("United Drug", "the Group" or "the Company"), a leading international provider of services to healthcare manufacturers and pharmaceutical retailers, will host an event for investors and analysts this morning, in London. Management will provide an overview of the company's strategy and its increasing international presence (currently 70% of group profits come from outside Ireland), a financial overview, as well as focusing in detail on the businesses, markets and opportunities of the three divisions.

 

United Drug issued an IMS on Tuesday 14 August 2012, for the period from 1 April 2012 to the date of the IMS and no further financial or trading update will be provided today.

 

Copies of the presentations will be available after the event at www.united-drug.com

 

ENDS

 

For reference:

 

Liam FitzGerald

Pauline McAlester

Greg Lawless/Lisa Kavanagh

Barry Mc Grane

Irish media

UK media

United Drug plc

Murray Consultants

Powerscourt

Tel: +353-1-4632300

Tel: +353-1-4980300

Tel: +44 207 250 1446

 

About United Drug plc

 

Listed on the Stock Exchanges in London and Dublin, United Drug is a leading international provider of services to healthcare manufacturers and pharmaceutical retailers, with operations in over 20 countries including: the UK, Ireland, Germany, the Netherlands, Belgium, and the USA. 

 

The Company operates across three divisions, Healthcare Supply Chain, Sales, Marketing & Medical, and Packaging & Specialty.

 

In Healthcare Supply Chain, United Drug is the largest pharmaceutical wholesaler in the island of Ireland. It is also the market leader in contract distribution outsourcing (pre-wholesaling) in Ireland and has achieved the No. 1 position in the UK through its joint venture business UniDrug Distribution Group (UDG). The Company provides specials medicines manufacturing and distribution services in the UK. Through its medical & scientific operations, United Drug provides sales & marketing and technical service solutions, including contract distribution services to a wide range of medical & scientific equipment & consumable manufacturers, with a market leading position in Ireland and an emerging presence in the UK.

 

In the Sales, Marketing & Medical division United Drug is a global leader in the provision of contract sales outsourcing services to pharmaceutical manufacturers with operations in major markets including Continental Europe, the UK, North America and a presence in South America. United Drug also provides related marketing services to pharmaceutical manufacturers in many of these markets.

 

In the Packaging & Specialty division United Drug is a leading international provider of pharmaceutical contract packaging and clinical trials materials services with facilities in the US, UK, Dutch and Belgian markets. The Company also provides speciality distribution and homecare services in the UK and Ireland.

 

For more information go to www.united-drug.com. 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCMMGMLGFDGZZM

Related Shares:

UDG.L
FTSE 100 Latest
Value8,275.66
Change0.00